Results 21 to 30 of about 1,106,155 (263)

Posttransplant Lymphoproliferative Disorders [PDF]

open access: yesAdvances in Hematology, 2012
Posttransplant lymphoproliferative disorders (PTLDs) are a group of diseases that range from benign polyclonal to malignant monoclonal lymphoid proliferations. They arise secondary to treatment with immunosuppressive drugs given to prevent transplant rejection.
Hazem Ibrahim, Kikkeri N. Naresh
openaire   +4 more sources

The potential usefulness of sputum cytology in the conclusive diagnosis of methotrexate-associated lymphoproliferative disorders: A case report

open access: yesSAGE Open Medical Case Reports, 2019
Background: Methotrexate has been used as an anchor drug for the treatment of rheumatoid arthritis and is considered to be a cause of methotrexate-associated lymphoproliferative disorder.
Seiya Mizuguchi   +4 more
doaj   +1 more source

Methotrexate-Associated Lymphoproliferative Disorder With Gingival Swelling

open access: yesAnnals of Internal Medicine: Clinical Cases, 2022
A 63-year-old Japanese man being treated for pemphigus vulgaris with methotrexate (MTX) presented with a fever of unknown origin. His only symptom at onset was mild gingival swelling. Suspected to have gingivitis, he was followed for 1 month. After that,
Saki Manabe   +8 more
doaj   +1 more source

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients [PDF]

open access: yes, 2014
An increased risk of posttransplant malignancy has been consistently reported following various solid organ transplants. The malignancies most commonly encountered are non-melanoma skin cancers, carcinomas of lung or breast and posttransplant ...
Savage, David G.   +7 more
core   +1 more source

Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation,

open access: yesTurkish Journal of Internal Medicine, 2022
Posttransplant lymphoproliferative diseases are complications that develop after solid organ transplantation. Primary EBV infection is one of the most important risk factors.
Ömer Candar, Tuğçe Zor Turna
doaj   +1 more source

Anemia in Lymphoproliferative Disorders [PDF]

open access: yesCancer Control, 1998
The onset of anemia in patients with lymphoproliferative disorders can be attributed to various causes, including autoimmune hemolytic anemia, pure red cell aplasia, and anemia of chronic disease. A variety of interventions can provide benefit.
openaire   +2 more sources

Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype [PDF]

open access: yes, 2000
Tumor necrosis factor (TNF) and Fas ligand (FasL) play major roles in the homeostasis of the peripheral immune system. This becomes dramatically obvious in the absence of a functional FasL.
Wilhelm, Patricia   +6 more
core   +3 more sources

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features

open access: yesCase Reports in Dermatology, 2018
Methotrexate-related lymphoproliferative disorder (MTX-LPD) is a rare disorder caused by long-term MTX therapy for autoimmune diseases. There has been no report of the dermoscopic features of MTX-LPD to date.
Takeshi Namiki   +4 more
doaj   +1 more source

Malignant Post-Transplant Lymphoproliferative Disorder of Nasopharynx in Myelodysplastic Disorder

open access: yes, 2021
(1) Background: Post-transplant lymphoproliferative disorder (PTLD) is a hematological disease and occurs because of immunosuppression after organ transplantation. Only a few studies have reported PTLD in the nasopharynx.
Geng-He Chang   +6 more
core   +1 more source

"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report " [PDF]

open access: yesActa Medica Iranica, 2003
Chronic myelogenous leukemia (CML) is a stem cell disorder sometimes associated with lymphoproliferative disorders. CML may precede a lymphoproliferative disorder.
"Ghavamzadeh A   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy